Inogen, Inc (INGN) by event type
INGN moves most on analyst upgrades — a median of +0.46% at 30 minutes across 13 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the INGN overview →
How INGN reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 401 of 2,717 | 13 | +0.46% | 54% | -0.46% |
| Rating reiterations 204 of 3,522 | 24 | +0.41% | 63% | +0.48% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how INGN usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Rating reiterations → · INGN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
| Protalix BioTherapeutics, Inc. (DE) (PLX) | 197 | 0.00% | 43% |
| AC Immune SA (ACIU) | 195 | -0.43% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.